A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC
Clinical trial NCT01829035 · COMPLETED
Trial details
- NCT number
- NCT01829035
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-21
- Primary completion
- 2017-06-21
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.